Dr John Coffin: XMRV and antiretrovirals

By Walter Armstrong:
"If you can't establish a disease association, then there is less interest in developing a drug, obviously." Coffin also notes that uncertainty remains about whether or not the virus is replicating. "If it does so, like HIV, then an antiretroviral would be very effective. But if not, as it appears in prostate cancer, a drug would not make any difference."
Source: http://pharmaceuticalvalidation.blogspot.com/2010/12/race-is-on.html